Osteopontin expression in gestational trophoblastic diseases: Correlation with expression of the adhesion molecule, CEACAM1

International Journal of Gynecological Pathology

Volumn 24, Issue 3, 2005, Pages 271-276

  Briese, Juliane ^a   Oberndörfer, Marine ^a   Schulte, Heinrich M ^b   Löning, Thomas ^a   Bamberger, A M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ENDOKRINOLOGIKUM HAMBURG   (Germany)

Author keywords

CEACAM1; Choriocarcinoma; Hydatidiform mole; Osteopontin; Trophoblastic tumor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE; OSTEOPONTIN;

ARTICLE; CELL PROLIFERATION; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; GESTATION PERIOD; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLASTIC DISEASE;

ANTIGENS, CD; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOPONTIN; PLACENTA; PREGNANCY; RETROSPECTIVE STUDIES; SIALOGLYCOPROTEINS;

EID: 21244492361     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000161810.10423.c7     Document Type: Article

References (35)

1. Shih IM, Kurman RJ. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Verh Dtsch Ges Pathol 1997;81:266-72.
2. Shih IM, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 1999;30:687-94.
3. Demir R, Vosanke G, Kohaven G, et al. Classification of human placenta. Microscop Res Tech. 1997;38:29-41.
4. Frank HG, Kaufmann P. Nonvillous parts and trophoblast invasion. In: Benirschke K, Kaufmann P, eds. Pathology of the Human Placenta. New York: Springer, 2000:171-272.
5. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001;20:31-47.
6. Liaw L, Almeida M, Hart CE, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995;95:713-24.
7. c-Monophosphate regulate osteopontin expression in human trophoblasts. Endocrinology 1996;137:1785-90.
8. Yue TL, McKenna PJ, Ohlstein EH, et al. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 1994;214:459-64.
9. Johnson GA, Burghardt RC, Bazer FW, et al. Osteopontin: roles in implantation and placentation. Biol Reprod 2003;69:1458-71.
10. Brown LF, Berse B, Van de Water L, et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992;3:1169-80.
11. Rittling SR, Novick KE. Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ 1997;8:101-69.
12. Briese J, Oberndöfer M, Schulte HM, Makigiannakis A, Löning T, Bamberger AM. Expression pattern of osteopontin (OPN) in the human placenta: correlation with expression of the adhesion molecule CEACAM1 (submitted).
13. Brümmer J, Ebrahimnejad A, Flayeh R, et al. Cis interaction of the cell adhesion molecule CEACAM1 with integrin beta3. Am J Pathol 2001;159:537-46.
14. Beauchemin N, Draber P, Dveksler G, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999;86:267-72.
15. Aurivillius M, Hansen OC, Lazrek MB, et al. The cell adhesion molecule Cell-CAM 105 is an etoATPase and a member of the immunoglobulin superfamily. FEBS Lett 1990;264:267-9.
16. Kuijpers TW, Hoogerwerf M, Van der Laan LJ, et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells. J Cell Biol 1992;118:457-66.
17. Barnett HT, Kretschmer A, Austen DA, et al. Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family. J Cell Biol 1989;108:267-76.
18. Thompson J, Grunett F, Zimmermann W. Carcinoembryonic antigen family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5:344-66.
19. Brümmer J, Neumaier M, Göpfert C, et al. Association of the pp60c-src with biliary Glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family down Regulated in colonic carcinomas. Oncogene 1995;11:1649-55.
20. Bamberger AM, Sudahl S, Löning T, et al. The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol 2000;156:1165-70.
21. Ebrahimnejad A, Streichert T, Nollau P, et al. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 2004;165:1781-7.
22. Bamberger AM, Sudahl S, Löning T, et al. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions. Am J Pathol 2000;156:1165-70.
23. Bamberger AM, Riethdorf L, Nollau P, et al. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 1998;152:1401-6.
24. Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York: Springer Verlag, 1995:1049-93.
25. Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998;22:1393-403.
26. Ohira S, Yamasaki T, Hatano H, et al. Epithelioid trophoblastic tumor metastatic to vagina: an immunohistochemical and ultrastructural study. Int J Gynecol Pathol 2000;19:381-6.
27. Kurman RJ, Main CS, Chen HC. Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta 1984;5:349-70.
28. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7:1475-82.
29. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11:279-303.
30. Nhijubo N, Uede T, Kon S, et al. Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncol 2000;11:135-46.
31. Morimoto J, Inobe M, Kimura C, et al. Osteopontin affects the persistence of β-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. Int J Immunol 2004;16:477-88.
32. Gabinskaya T, Salafia CM, Gulle VE, Holzman IR, Weintraub AS. Gestational age-dependent extravillous cytotrophoblast osteopontin immunolocalization differentiates between normal and preeclamptic pregnancies. Am J Reprod Immunol 1998;40:339-46.
33. Batorfi J, Fulop V, Kim JH, et al. Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol 2003;89:134-39.
34. Kim JH, Skates SJ, Uede T, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002;287:1671-9.
35. Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004;10:184-90.